Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Metropolis Healthcare Ltd. ( (IN:METROPOLIS) ) is now available.
Metropolis Healthcare has secured shareholder approval via a postal ballot and remote e-voting to issue bonus shares, with the resolution passed by the requisite majority. The process was conducted electronically in line with Companies Act provisions, SEBI listing norms and recent Ministry of Corporate Affairs circulars, with National Securities Depository Limited facilitating the e-voting and the scrutinizer confirming due compliance and result publication on the company’s website.
The bonus share approval signals a capital allocation move that may enhance liquidity in Metropolis Healthcare’s stock and reward existing shareholders without immediate cash outflow. By executing the vote through a fully digital, regulator-compliant process, the company underlines its governance standards and engagement with a broad shareholder base, reinforcing its position as a well-regulated listed diagnostics player.
More about Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd. operates in the diagnostic healthcare industry, offering pathology and laboratory testing services across India. The company focuses on providing clinical testing and related diagnostic solutions to patients and healthcare providers, and its shares are listed on both BSE and the National Stock Exchange of India.
Average Trading Volume: 6,889
Technical Sentiment Signal: Sell
Current Market Cap: 92.7B INR
See more insights into METROPOLIS stock on TipRanks’ Stock Analysis page.